Skip to content

Effect of JieJiXuanFeiChuYi Granule on Patients with COVID 19 (Omicron): A Randomized Controlled Trial

Effect of JieJiXuanFeiChuYi Granule on Patients with COVID 19 (Omicron): A Randomized, Open-label, Active drug Parallel Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005799
Enrollment
Unknown
Registered
2022-04-03
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid 19 (Omicron) infection

Interventions

Test Group:JieJiXuanFeiChuYi Granule

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for patients with Covid 19 in the "Covid 19 Pneumonia Diagnosis and Treatment Program (Trial Version 9)"; 2. The clinical classification is mild and moderate; 3. Diagnosed within 72 hours; 4. Have one or more symptoms of fever, cough, and fatigue; 5. The patient's aged >=18 years; 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe and Critical type; 2. Women preparing for pregnancy, pregnant and lactating women; 3. Allergic constitution patients (referring to those allergic to two or more drugs or foods or to the known ingredients of the drug in this trial); 4. Mental patients, or patients without self-awareness. 5. Not suitable to participate in clinical trials judged by the investigator.

Design outcomes

Secondary

MeasureTime frame
Clinical symptoms recovery time;Single symptom disappearance time;Nucleic acid negative rate;Fever reduction time;Nucleic acid negative time;Clinical symptoms recovery rate;Single symptom disappearance rate;Blood routine test;Hospitalization time;

Countries

China

Contacts

Public ContactShi Li
shili0648@163.com+86 15948000558

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026